A review of the clinical experience in pulsed dose rate brachytherapy
Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Balgobind, Brian V [verfasserIn] |
|---|
| Format: |
Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Systematik: |
|
|---|
| Übergeordnetes Werk: |
Enthalten in: The British journal of radiology - Oxford : Oxford University Press, 1928, 88(2015), 1055 |
|---|---|
| Übergeordnetes Werk: |
volume:88 ; year:2015 ; number:1055 |
| Links: |
|---|
| DOI / URN: |
10.1259/bjr.20150310 |
|---|
| Katalog-ID: |
OLC1964096723 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1964096723 | ||
| 003 | DE-627 | ||
| 005 | 20230516224056.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1259/bjr.20150310 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1964096723 | ||
| 035 | |a (DE-599)GBVOLC1964096723 | ||
| 035 | |a (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 | ||
| 035 | |a (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a XA 34700 |q AVZ |2 rvk | ||
| 084 | |a 44.64 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Balgobind, Brian V |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A review of the clinical experience in pulsed dose rate brachytherapy |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. | ||
| 700 | 1 | |a Koedooder, Kees |4 oth | |
| 700 | 1 | |a Ordoñez Zúñiga, Diego |4 oth | |
| 700 | 1 | |a Dávila Fajardo, Raquel |4 oth | |
| 700 | 1 | |a Rasch, Coen R N |4 oth | |
| 700 | 1 | |a Pieters, Bradley R |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of radiology |d Oxford : Oxford University Press, 1928 |g 88(2015), 1055 |w (DE-627)129077976 |w (DE-600)2982-8 |w (DE-576)014410524 |x 0007-1285 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2015 |g number:1055 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1259/bjr.20150310 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26290399 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHY | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 936 | r | v | |a XA 34700 |
| 936 | b | k | |a 44.64 |q AVZ |
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 88 |j 2015 |e 1055 | ||
| author_variant |
b v b bv bvb |
|---|---|
| matchkey_str |
article:00071285:2015----::rveotelnclxeinenusdoe |
| hierarchy_sort_str |
2015 |
| bklnumber |
44.64 44.40 |
| publishDate |
2015 |
| allfields |
10.1259/bjr.20150310 doi PQ20160617 (DE-627)OLC1964096723 (DE-599)GBVOLC1964096723 (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach DE-627 ger DE-627 rakwb eng 610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl Balgobind, Brian V verfasserin aut A review of the clinical experience in pulsed dose rate brachytherapy 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. Koedooder, Kees oth Ordoñez Zúñiga, Diego oth Dávila Fajardo, Raquel oth Rasch, Coen R N oth Pieters, Bradley R oth Enthalten in The British journal of radiology Oxford : Oxford University Press, 1928 88(2015), 1055 (DE-627)129077976 (DE-600)2982-8 (DE-576)014410524 0007-1285 nnns volume:88 year:2015 number:1055 http://dx.doi.org/10.1259/bjr.20150310 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26290399 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_24 GBV_ILN_74 GBV_ILN_170 GBV_ILN_4012 GBV_ILN_4219 GBV_ILN_4305 XA 34700 44.64 AVZ 44.40 AVZ AR 88 2015 1055 |
| spelling |
10.1259/bjr.20150310 doi PQ20160617 (DE-627)OLC1964096723 (DE-599)GBVOLC1964096723 (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach DE-627 ger DE-627 rakwb eng 610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl Balgobind, Brian V verfasserin aut A review of the clinical experience in pulsed dose rate brachytherapy 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. Koedooder, Kees oth Ordoñez Zúñiga, Diego oth Dávila Fajardo, Raquel oth Rasch, Coen R N oth Pieters, Bradley R oth Enthalten in The British journal of radiology Oxford : Oxford University Press, 1928 88(2015), 1055 (DE-627)129077976 (DE-600)2982-8 (DE-576)014410524 0007-1285 nnns volume:88 year:2015 number:1055 http://dx.doi.org/10.1259/bjr.20150310 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26290399 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_24 GBV_ILN_74 GBV_ILN_170 GBV_ILN_4012 GBV_ILN_4219 GBV_ILN_4305 XA 34700 44.64 AVZ 44.40 AVZ AR 88 2015 1055 |
| allfields_unstemmed |
10.1259/bjr.20150310 doi PQ20160617 (DE-627)OLC1964096723 (DE-599)GBVOLC1964096723 (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach DE-627 ger DE-627 rakwb eng 610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl Balgobind, Brian V verfasserin aut A review of the clinical experience in pulsed dose rate brachytherapy 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. Koedooder, Kees oth Ordoñez Zúñiga, Diego oth Dávila Fajardo, Raquel oth Rasch, Coen R N oth Pieters, Bradley R oth Enthalten in The British journal of radiology Oxford : Oxford University Press, 1928 88(2015), 1055 (DE-627)129077976 (DE-600)2982-8 (DE-576)014410524 0007-1285 nnns volume:88 year:2015 number:1055 http://dx.doi.org/10.1259/bjr.20150310 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26290399 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_24 GBV_ILN_74 GBV_ILN_170 GBV_ILN_4012 GBV_ILN_4219 GBV_ILN_4305 XA 34700 44.64 AVZ 44.40 AVZ AR 88 2015 1055 |
| allfieldsGer |
10.1259/bjr.20150310 doi PQ20160617 (DE-627)OLC1964096723 (DE-599)GBVOLC1964096723 (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach DE-627 ger DE-627 rakwb eng 610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl Balgobind, Brian V verfasserin aut A review of the clinical experience in pulsed dose rate brachytherapy 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. Koedooder, Kees oth Ordoñez Zúñiga, Diego oth Dávila Fajardo, Raquel oth Rasch, Coen R N oth Pieters, Bradley R oth Enthalten in The British journal of radiology Oxford : Oxford University Press, 1928 88(2015), 1055 (DE-627)129077976 (DE-600)2982-8 (DE-576)014410524 0007-1285 nnns volume:88 year:2015 number:1055 http://dx.doi.org/10.1259/bjr.20150310 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26290399 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_24 GBV_ILN_74 GBV_ILN_170 GBV_ILN_4012 GBV_ILN_4219 GBV_ILN_4305 XA 34700 44.64 AVZ 44.40 AVZ AR 88 2015 1055 |
| allfieldsSound |
10.1259/bjr.20150310 doi PQ20160617 (DE-627)OLC1964096723 (DE-599)GBVOLC1964096723 (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach DE-627 ger DE-627 rakwb eng 610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl Balgobind, Brian V verfasserin aut A review of the clinical experience in pulsed dose rate brachytherapy 2015 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. Koedooder, Kees oth Ordoñez Zúñiga, Diego oth Dávila Fajardo, Raquel oth Rasch, Coen R N oth Pieters, Bradley R oth Enthalten in The British journal of radiology Oxford : Oxford University Press, 1928 88(2015), 1055 (DE-627)129077976 (DE-600)2982-8 (DE-576)014410524 0007-1285 nnns volume:88 year:2015 number:1055 http://dx.doi.org/10.1259/bjr.20150310 Volltext http://www.ncbi.nlm.nih.gov/pubmed/26290399 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_24 GBV_ILN_74 GBV_ILN_170 GBV_ILN_4012 GBV_ILN_4219 GBV_ILN_4305 XA 34700 44.64 AVZ 44.40 AVZ AR 88 2015 1055 |
| language |
English |
| source |
Enthalten in The British journal of radiology 88(2015), 1055 volume:88 year:2015 number:1055 |
| sourceStr |
Enthalten in The British journal of radiology 88(2015), 1055 volume:88 year:2015 number:1055 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The British journal of radiology |
| authorswithroles_txt_mv |
Balgobind, Brian V @@aut@@ Koedooder, Kees @@oth@@ Ordoñez Zúñiga, Diego @@oth@@ Dávila Fajardo, Raquel @@oth@@ Rasch, Coen R N @@oth@@ Pieters, Bradley R @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
129077976 |
| dewey-sort |
3610 |
| id |
OLC1964096723 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1964096723</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230516224056.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160206s2015 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1259/bjr.20150310</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160617</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1964096723</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1964096723</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XA 34700</subfield><subfield code="q">AVZ</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.64</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Balgobind, Brian V</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A review of the clinical experience in pulsed dose rate brachytherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koedooder, Kees</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ordoñez Zúñiga, Diego</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dávila Fajardo, Raquel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rasch, Coen R N</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pieters, Bradley R</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">The British journal of radiology</subfield><subfield code="d">Oxford : Oxford University Press, 1928</subfield><subfield code="g">88(2015), 1055</subfield><subfield code="w">(DE-627)129077976</subfield><subfield code="w">(DE-600)2982-8</subfield><subfield code="w">(DE-576)014410524</subfield><subfield code="x">0007-1285</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:88</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1055</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1259/bjr.20150310</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/26290399</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">XA 34700</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.64</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">88</subfield><subfield code="j">2015</subfield><subfield code="e">1055</subfield></datafield></record></collection>
|
| author |
Balgobind, Brian V |
| spellingShingle |
Balgobind, Brian V ddc 610 rvk XA 34700 bkl 44.64 bkl 44.40 A review of the clinical experience in pulsed dose rate brachytherapy |
| authorStr |
Balgobind, Brian V |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)129077976 |
| format |
Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
OLC |
| remote_str |
false |
| illustrated |
Not Illustrated |
| issn |
0007-1285 |
| topic_title |
610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl A review of the clinical experience in pulsed dose rate brachytherapy |
| topic |
ddc 610 rvk XA 34700 bkl 44.64 bkl 44.40 |
| topic_unstemmed |
ddc 610 rvk XA 34700 bkl 44.64 bkl 44.40 |
| topic_browse |
ddc 610 rvk XA 34700 bkl 44.64 bkl 44.40 |
| format_facet |
Aufsätze Gedruckte Aufsätze |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
nc |
| author2_variant |
k k kk z d o zd zdo f r d fr frd c r n r crn crnr b r p br brp |
| hierarchy_parent_title |
The British journal of radiology |
| hierarchy_parent_id |
129077976 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
The British journal of radiology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)129077976 (DE-600)2982-8 (DE-576)014410524 |
| title |
A review of the clinical experience in pulsed dose rate brachytherapy |
| ctrlnum |
(DE-627)OLC1964096723 (DE-599)GBVOLC1964096723 (PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960 (KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach |
| title_full |
A review of the clinical experience in pulsed dose rate brachytherapy |
| author_sort |
Balgobind, Brian V |
| journal |
The British journal of radiology |
| journalStr |
The British journal of radiology |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
txt |
| author_browse |
Balgobind, Brian V |
| container_volume |
88 |
| class |
610 DNB XA 34700 AVZ rvk 44.64 bkl 44.40 bkl |
| format_se |
Aufsätze |
| author-letter |
Balgobind, Brian V |
| doi_str_mv |
10.1259/bjr.20150310 |
| dewey-full |
610 |
| title_sort |
review of the clinical experience in pulsed dose rate brachytherapy |
| title_auth |
A review of the clinical experience in pulsed dose rate brachytherapy |
| abstract |
Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. |
| abstractGer |
Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. |
| abstract_unstemmed |
Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-PHY SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_24 GBV_ILN_74 GBV_ILN_170 GBV_ILN_4012 GBV_ILN_4219 GBV_ILN_4305 |
| container_issue |
1055 |
| title_short |
A review of the clinical experience in pulsed dose rate brachytherapy |
| url |
http://dx.doi.org/10.1259/bjr.20150310 http://www.ncbi.nlm.nih.gov/pubmed/26290399 |
| remote_bool |
false |
| author2 |
Koedooder, Kees Ordoñez Zúñiga, Diego Dávila Fajardo, Raquel Rasch, Coen R N Pieters, Bradley R |
| author2Str |
Koedooder, Kees Ordoñez Zúñiga, Diego Dávila Fajardo, Raquel Rasch, Coen R N Pieters, Bradley R |
| ppnlink |
129077976 |
| mediatype_str_mv |
n |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1259/bjr.20150310 |
| up_date |
2024-07-04T07:10:59.989Z |
| _version_ |
1803631523245588480 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a2200265 4500</leader><controlfield tag="001">OLC1964096723</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230516224056.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">160206s2015 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1259/bjr.20150310</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">PQ20160617</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1964096723</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1964096723</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PRQ)c1495-be5ddb8863be551aeb0bcc0206394118ac30ead0eeacb45f7fec9fa5e08d36960</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(KEY)0026188220150000088105500000reviewoftheclinicalexperienceinpulseddoseratebrach</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DNB</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XA 34700</subfield><subfield code="q">AVZ</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.64</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Balgobind, Brian V</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="2"><subfield code="a">A review of the clinical experience in pulsed dose rate brachytherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pulsed dose rate (PDR) brachytherapy is a treatment modality that combines physical advantages of high dose rate (HDR) brachytherapy with the radiobiological advantages of low dose rate brachytherapy. The aim of this review was to describe the effective clinical use of PDR brachytherapy worldwide in different tumour locations. We found 66 articles reporting on clinical PDR brachytherapy including the treatment procedure and outcome. Moreover, PDR brachytherapy has been applied in almost all tumour sites for which brachytherapy is indicated and with good local control and low toxicity. The main advantage of PDR is, because of the small pulse sizes used, the ability to spare normal tissue. In certain cases, HDR resembles PDR brachytherapy by the use of multifractionated low-fraction dose.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koedooder, Kees</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ordoñez Zúñiga, Diego</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dávila Fajardo, Raquel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rasch, Coen R N</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pieters, Bradley R</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">The British journal of radiology</subfield><subfield code="d">Oxford : Oxford University Press, 1928</subfield><subfield code="g">88(2015), 1055</subfield><subfield code="w">(DE-627)129077976</subfield><subfield code="w">(DE-600)2982-8</subfield><subfield code="w">(DE-576)014410524</subfield><subfield code="x">0007-1285</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:88</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:1055</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://dx.doi.org/10.1259/bjr.20150310</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">http://www.ncbi.nlm.nih.gov/pubmed/26290399</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4219</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">XA 34700</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.64</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">88</subfield><subfield code="j">2015</subfield><subfield code="e">1055</subfield></datafield></record></collection>
|
| score |
7.3993883 |